APYX
Apyx Medical CorporationNASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
10.67
P/S
2.91
EV/EBITDA
-33.15
DCF Value
$-4.62
FCF Yield
-5.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
36.0%
Operating Margin
-12.2%
Net Margin
-21.2%
ROE
-117.5%
ROA
-16.8%
ROIC
-11.6%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $19.2M | $-1.3M | $-0.03 |
| FY 2025 | $52.8M | $-11.2M | $-0.27 |
| Q3 2025 | $12.9M | $-2.0M | $-0.05 |
| Q2 2025 | $11.4M | $-3.8M | $-0.09 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
1.54
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.